Laboratory assessment of hypercoagulable state: A study in a group of patients with venous thromboembolism born in Chioggia

Minerva Medica

Volumn 98, Issue 2, 2007, Pages 89-93

  Gessoni, G ^a,c   Valverde, S ^a   Canistro, R ^a   Trabuio, E ^a   Antico, F ^a   Manoni, F ^b  

^a Chioggia Civil Hospital   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Ospedale Civile   (Italy)

Author keywords

Factor V Leiden; Laboratories; Risk factors; Thrombophilia; Venous thrombosis

Indexed keywords

ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 5 LEIDEN; CARDIOLIPIN; D DIMER; FIBRINOGEN; HOMOCYSTEINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; PROTHROMBIN ANTIBODY;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ANTITHROMBIN III DEFICIENCY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HYPERCOAGULABILITY; HYPERHOMOCYSTEINEMIA; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; RISK FACTOR; THROMBOPHILIA;

ADULT; AGED; ANTITHROMBIN III DEFICIENCY; FACTOR V; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MUTATION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 34447532359     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Tripodi A, P Mannucci. Laboratory investigation of thrombophilia. Clin Chem 2001;47:1597-606.
2. Somma J, Sussman I, Rand J. An evaluation of thrombophilia screening in an urban tertiary care medical center: a "real word" experience. Am J Clin Pathol 2006;126:1-8.
3. Leagues, Hooper W. Molecular diagnosis of inheroted thrombosis. Clin Lab Sci 2005;18:271-9.
4. Moll S. Thrombophilias - practical implications and testing caveat. J Thromb Thrombolysis 2006;21:7-15.
5. Wilmer M, Stocker C, Buhler B, Conell B, Calatzis A. Improved distinction of factor V wild-type anf Factor V Leiden using a novel prothrombin based activated Protein C resistance assay. Am J Clin Pathol 2004;122:836-42.
6. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002;87:1095-108.
7. Paschoa A, Guillaumon A. Impact of screening on thrombophilia for patients with venous thrombosis. Int Angiol 2006;25:52-9.
8. Franchini M, Veneri D, Salvagno G, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci 2006;43: 249-50.
9. Vig S, Chitolie A, Bevan D, Dormandy J, Thompson M, Halliday A. The prevalence of thrombophilia in patients with symptomatic peripheral vascular didease. Br J Surg 2006;93:577-81.